Triggering aggressive forms of leukaemia or an incurable spinal cord disease that leads to paralysis. HTLV-1 virus is the often ignored but no less insidious sibling of the AIDS pathogen HIV, also belonging to the retroviruses. A group of researchers from the TU Dresden, the company PROVIREX Genome Editing Therapies and the Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have now provided initial proof of concept for a possible therapeutic approach.
Read here the original Press Release.